Autoinjectors - Global Strategic Business Report

Global Autoinjectors Market to Reach $168.2 Billion by 2030

The global market for Autoinjectors estimated at US$50.9 Billion in the year 2022, is projected to reach a revised size of US$168.2 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2022-2030. Rheumatoid Arthritis, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$47.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Anaphylaxis segment is readjusted to a revised 15.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $13.9 Billion, While China is Forecast to Grow at 21.4% CAGR

The Autoinjectors market in the U.S. is estimated at US$13.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$40.4 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 13.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$26.4 Billion by the year 2030.

Select Competitors (Total 42 Featured) -

• AbbVie, Inc.
• Amgen, Inc.
• Antares Pharma, Inc.
• Becton, Dickinson and Company
• Consort Medical PLC
• Eli Lilly and Company
• Haselmeier GmbH
• Mylan NV
• Owen Mumford Ltd.
• SHL Group
• Teva Pharmaceutical Industries Ltd.
• Ypsomed AG

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year